Molecular Trojan Horses for treating lysosomal storage diseases
Andrés Felipe Leal(Icesi University), Shunji Tomatsu(Alfred I. duPont Hospital for Children), Diego A. Súarez(Pontificia Universidad Javeriana), Volkan Seyrantepe(Izmir Institute of Technology), Carlos Javier Alméciga-Díaz(Pontificia Universidad Javeriana), Estera Rintz(University of Gdańsk), Orhan Kerim İnci(Izmir Institute of Technology), Betül Çelik(Nemours Children's Health System), Daniel León(Pontificia Universidad Javeriana), Yasuhiko Ago(Nemours Children's Health System)
Cited by 7
Related Papers
Neu4, a Novel Human Lysosomal Lumen Sialidase, Confers Normal Phenotype to Sialidosis and Galactosialidosis Cells
|Journal of Biological Chemistry|2004|145
Regulation of Phagocytosis in Macrophages by Neuraminidase 1
|Journal of Biological Chemistry|2009|96
Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease
|Experimental Neurology|2017|82
GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease
|Journal of Neuroinflammation|2020|65
Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses
|International Journal of Molecular Sciences|2020|27